(Q34812028)

4 August 2017

1 reference

title

DNA-based immunotherapy: potential for treatment of chronic viral hepatitis? (English)

1 reference

4 August 2017

1 reference

3

Guido Gerken

1 reference

4 August 2017

1

Susanne Beckebaum

1 reference

4 August 2017

2

Vito R Cicinnati

1 reference

4 August 2017

1 September 2002

1 reference

Reviews in Medical Virology

4 August 2017

23

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

4 August 2017

12

1 reference

4 August 2017

5

1 reference

4 August 2017

297-319

1 reference

Pathogenesis of hepatocellular carcinoma

4 August 2017

1 reference

Hepatitis B and hepatitis C co-infection in patients with HIV.

21 January 2018

1 reference

Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases

21 January 2018

1 reference

Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance

21 January 2018

1 reference

Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg

21 January 2018

1 reference

In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus

21 January 2018

1 reference

Response to hepatitis B vaccine: multiple HLA genes are involved.

21 January 2018

1 reference

HLA-DRB1*1301 AND *1302 protect against chronic hepatitis B

21 January 2018

1 reference

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

21 January 2018

1 reference

An open-label trial of consensus interferon 15 µg in the treatment of Chinese patients with chronic hepatitis C.

21 January 2018

1 reference

Selection of hepatitis B virus variants with aminoacid substitutions inside the core antigen during interferon-alpha therapy

21 January 2018

1 reference

Vaccination of chronic hepatitis B virus carriers with preS2/S envelope protein is not associated with the emergence of envelope escape mutants

21 January 2018

1 reference

Combination therapy of active HBsAg vaccination and interferon-alpha in interferon-alpha nonresponders with chronic hepatitis B.

21 January 2018

1 reference

Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine

21 January 2018

1 reference

Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.

21 January 2018

1 reference

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

21 January 2018

1 reference

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

The origin and evolution of hepatitis viruses in humans

21 January 2018

1 reference

Hepatitis C virus variability: sequence analysis of an isolate after 10 years of chronic infection

21 January 2018

1 reference

Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation

21 January 2018

1 reference

[37] Antisense oligonucleotide therapy of hepadnavirus infection

21 January 2018

1 reference

Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes

21 January 2018

1 reference

Pharmacokinetics and tissue distribution of a ribozyme directed against hepatitis C virus RNA following subcutaneous or intravenous administration in mice

21 January 2018

1 reference

Hepatitis B virus immunopathogenesis

21 January 2018

1 reference

Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection

21 January 2018

1 reference

Studies of human antiviral CD8+ lymphocytes using class I peptide tetramers

21 January 2018

1 reference

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

21 January 2018

1 reference

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

21 January 2018

1 reference

Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B.

21 January 2018

1 reference

The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome

21 January 2018

1 reference

Analysis of a successful immune response against hepatitis C virus

21 January 2018

1 reference

Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.

21 January 2018

1 reference

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

21 January 2018

1 reference

Induction of cytokine production and proliferation of memory lymphocytes by murine liver dendritic cell progenitors: role of these progenitors as immunogenic resident antigen-presenting cells in the liver.

21 January 2018

1 reference

Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection

21 January 2018

1 reference

Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection

21 January 2018

1 reference

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

21 January 2018

1 reference

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

Plasmid DNA-based immunization for hepatitis C virus structural proteins: immune responses in mice

21 January 2018

1 reference

Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen

21 January 2018

1 reference

DNA-based immunization against hepatitis B virus

21 January 2018

1 reference

DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state

21 January 2018

1 reference

DNA vaccines: immunology, application, and optimization*

21 January 2018

1 reference

Direct gene transfer into mouse muscle in vivo

21 January 2018

1 reference

DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines

21 January 2018

1 reference

Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control

21 January 2018

1 reference

Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses.

21 January 2018

1 reference

DNA-mediated immunization to hepatitis B virus envelope proteins: preS antigen secretion enhances the humoral response.

21 January 2018

1 reference

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

21 January 2018

1 reference

Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice

21 January 2018

1 reference

DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

21 January 2018

1 reference

DNA-mediated immunization: prospects for hepatitis B vaccination

21 January 2018

1 reference

DNA vaccines for viral diseases

21 January 2018

1 reference

Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid.

21 January 2018

1 reference

Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigen

21 January 2018

1 reference

Evaluation of new approaches to prophylactic and therapeutic vaccinations against hepatitis B viruses in the woodchuck model

21 January 2018

1 reference

Immunization of woodchucks (Marmota monax) with hepatitis delta virus DNA vaccine

21 January 2018

1 reference

Vaccination against hepatitis delta virus infection: studies in the woodchuck (Marmota monax) model

21 January 2018

1 reference

Cell-based and animal models for hepatitis B and C viruses

21 January 2018

1 reference

New animal models of hepatitis B and C.

21 January 2018

1 reference

Transgenic technology and the study of hepatitis viruses: a review of what we have learned

21 January 2018

1 reference

Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system

21 January 2018

1 reference

Transgenic expression of hepatitis C virus structural proteins in the mouse

21 January 2018

1 reference

Hepatitis C virus replication in mice with chimeric human livers

21 January 2018

1 reference

Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.

21 January 2018

1 reference

Repeated administration of hepatitis C virus core-encoding plasmid to mice does not necessarily increase the immune response generated against this antigen

21 January 2018

1 reference

Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice

21 January 2018

1 reference

Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by an intrahepatic inoculation with an expression plasmid

21 January 2018

1 reference

Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus

21 January 2018

1 reference

Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination

21 January 2018

1 reference

Persistent, antigen-specific, therapeutic antitumor immunity by dendritic cells genetically modified with an adenoviral vector to express a model tumor antigen

21 January 2018

1 reference

DNA-mediated immunization of mice with plasmid encoding HBs antigen

21 January 2018

1 reference

A single immunization with a plasmid encoding hepatitis C virus (HCV) structural proteins under the elongation factor 1-alpha promoter elicits HCV-specific cytotoxic T-lymphocytes (CTL).

21 January 2018

1 reference

DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface.

21 January 2018

1 reference

Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization

21 January 2018

1 reference

Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.

21 January 2018

1 reference

Immune responses to hepatitis B virus surface and core antigens in mice, monkeys, and pigs after Accell particle-mediated DNA immunization

21 January 2018

1 reference

Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.

21 January 2018

1 reference

Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway

21 January 2018

1 reference

Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations

21 January 2018

1 reference

Construction of adenoviral and retroviral vectors coexpressing the genes encoding the hepatitis B surface antigen and B7-1 protein

21 January 2018

1 reference

Adenoviral vectors for gene transfer

21 January 2018

1 reference

Gene therapy of viral hepatitis and hepatocellular carcinoma.

21 January 2018

1 reference

Progress with retroviral gene vectors

21 January 2018

1 reference

Characterization of a new class of DNA delivery complexes formed by the local anesthetic bupivacaine

21 January 2018

1 reference

Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression

21 January 2018

1 reference

DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody

21 January 2018

1 reference

Update on antiviral DNA vaccine research (1998-2000).

21 January 2018

1 reference

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans

21 January 2018

1 reference

Coadministration of gamma interferon with DNA vaccine expressing woodchuck hepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection

21 January 2018

1 reference

Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization

21 January 2018

1 reference

Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigen

21 January 2018

1 reference

Improved immunogenicity of HIV-1 epitopes in HBsAg chimeric DNA vaccine plasmids by structural mutations of HBsAg

21 January 2018

1 reference

In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen.

21 January 2018

1 reference

Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines

21 January 2018

1 reference

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers.

21 January 2018

1 reference

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

21 January 2018

1 reference

Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100.

21 January 2018

1 reference

Dendritic cell-based immunotherapy of renal cell carcinoma.

21 January 2018

1 reference

Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1.

21 January 2018

1 reference

Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.

21 January 2018

1 reference

Assuring the quality, safety, and efficacy of DNA vaccines

21 January 2018

1 reference

Potential DNA vaccine integration into host cell genome

21 January 2018

1 reference

Tumor immunity and autoimmunity induced by immunization with homologous DNA

21 January 2018

1 reference

DNA vaccines: safety and efficacy issues

21 January 2018

1 reference

Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RMV.359

1 reference

4 August 2017

1 reference

PubMed ID

12211043